Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients3

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients1

Views

Views
December 20230
January 20240
February 20240
March 20240
April 20240
May 20241
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States1
 

Top cities views

Views
Fort Worth1